| Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Cancer discovery 7 (5), 462-477, 2017 | 944 | 2017 |
| Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma MC Chamberlain, CS Baik, VK Gadi, S Bhatia, LQM Chow Neuro-oncology 19 (1), i1-i24, 2017 | 189 | 2017 |
| Fetal microchimerism in women with breast cancer VK Gadi, JL Nelson Cancer research 67 (19), 9035-9038, 2007 | 154 | 2007 |
| Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection VK Gadi, JL Nelson, ND Boespflug, KA Guthrie, CS Kuhr Clinical chemistry 52 (3), 379-382, 2006 | 136 | 2006 |
| PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake LK Dunnwald, RK Doot, JM Specht, JR Gralow, GK Ellis, RB Livingston, ... Clinical Cancer Research 17 (8), 2400-2409, 2011 | 131 | 2011 |
| Adjuvant trastuzumab emtansine versus paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT): a randomized clinical trial SM Tolaney, N Tayob, C Dang, DA Yardley, SJ Isakoff, V Valero, ... Journal of Clinical Oncology 39 (21), 2375-2385, 2021 | 130 | 2021 |
| Bystander Killing of Melanoma Cells Using the Human Tyrosinase Promoter to Express the Escherichia coli Purine Nucleoside Phosphorylase Gene BW Hughes, AH Wells, Z Bebok, VK Gadi, RI Garver Jr, WB Parker, ... Cancer research 55 (15), 3339-3345, 1995 | 117 | 1995 |
| A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC) LM Peterson, BF Kurland, EK Schubert, JM Link, VK Gadi, JM Specht, ... Molecular imaging and biology 16, 431-440, 2014 | 114 | 2014 |
| Case-control study of fetal microchimerism and breast cancer VK Gadi, KE Malone, KA Guthrie, PL Porter, JL Nelson PLoS One 3 (3), e1706, 2008 | 103 | 2008 |
| Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated … ET Rodler, BF Kurland, M Griffin, JR Gralow, P Porter, RF Yeh, VK Gadi, ... Clinical Cancer Research 22 (12), 2855-2864, 2016 | 100 | 2016 |
| Practical approach to triple-negative breast cancer VK Gadi, NE Davidson Journal of oncology practice 13 (5), 293-300, 2017 | 99 | 2017 |
| In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells VK Gadi, SD Alexander, JE Kudlow, P Allan, WB Parker, EJ Sorscher Gene therapy 7 (20), 1738-1743, 2000 | 90 | 2000 |
| Opposite effects of microchimerism on breast and colon cancer M Kamper-Jørgensen, RJ Biggar, A Tjønneland, H Hjalgrim, N Kroman, ... European journal of cancer 48 (14), 2227-2235, 2012 | 75 | 2012 |
| Fetal microchimerism in breast from women with and without breast cancer VK Gadi Breast cancer research and treatment 121, 241-244, 2010 | 69 | 2010 |
| Personalized In vitro and C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Vivo Cancer Models to Guide Precision Medicine, In: Cancer Discov. 2017; 7 …, 2017 | 64 | 2017 |
| Gene Therapy of Cancer: Activation of Nucleoside Prodrugs with E. coli Purine Nucleoside Phosphorylase JA Secrist III, WB Parker, PW Allan, LL Bennett Jr, WR Waud, JW Truss, ... Nucleosides, Nucleotides & Nucleic Acids 18 (4-5), 745-757, 1999 | 64 | 1999 |
| Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism Z Yan, T Aydelotte, VK Gadi, KA Guthrie, JL Nelson Arthritis & Rheumatism 63 (3), 640-644, 2011 | 56 | 2011 |
| Skewed X-chromosome inactivation in scleroderma E Uz, LS Loubiere, VK Gadi, Z Ozbalkan, J Stewart, JL Nelson, T Ozcelik Clinical reviews in allergy & immunology 34, 352-355, 2008 | 55 | 2008 |
| Fetal microchimerism and cancer VK Gadi Cancer Letters 276 (1), 8-13, 2009 | 53 | 2009 |
| Prospective study of serial 18F-FDG PET and 18F-fluoride PET to predict time to skeletal-related events, time to progression, and survival in patients with bone-dominant … LM Peterson, J O’Sullivan, QV Wu, A Novakova-Jiresova, I Jenkins, ... Journal of Nuclear Medicine 59 (12), 1823-1830, 2018 | 52 | 2018 |
